Kodiak Sciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KOD and other ETFs, options, and stocks.

About KOD

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD.

CEO

Victor Perlroth

CEOVictor Perlroth

Employees

109

Employees109

Headquarters

Palo Alto, California

HeadquartersPalo Alto, California

Founded

2009

Founded2009

Employees

109

Employees109

KOD Key Statistics

Market cap

221.02M

Market cap221.02M

Price-Earnings ratio

-1.25

Price-Earnings ratio-1.25

Dividend yield

—

Dividend yield—

Average volume

492.24K

Average volume492.24K

High today

$4.23

High today$4.23

Low today

$3.77

Low today$3.77

Open price

$3.98

Open price$3.98

Volume

398.70K

Volume398.70K

52 Week high

$11.60

52 Week high$11.60

52 Week low

$1.92

52 Week low$1.92

KOD News

Simply Wall St 7d

April 2025's Promising Penny Stocks

Over the last 7 days, the market has remained flat, but it is up 5.7% over the past year, with earnings forecast to grow by 13% annually. Though the term 'penny...